List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 23 studies with search of:   Georgia
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Aldosterone Antagonist Therapy for Adults With Heart Failure and Preserved Systolic Function
Conditions: Cardiovascular Diseases;   Heart Diseases;   Heart Failure, Congestive
Interventions: Drug: Aldosterone Antagonist (spironolactone);   Drug: Placebo
2 Recruiting FRANCIS-ACS Trial: A Study of the Safety and Efficacy of A 002 in Subjects With Acute Coronary Syndromes
Condition: Acute Coronary Syndrome
Intervention: Drug: Varespladib Methyl (A-002)
3 Recruiting RE-DEEM Dose Finding Study for Dabigatran Etexilate in Patients With Acute Coronary Syndrome
Condition: Coronary Disease
Interventions: Drug: Dabigatran etexilate;   Drug: Placebo
4 Completed Pharmacokinetics (PK) And Tolerability of Intravenous (IV) and Oral CK-1827452 in Patients With Ischemic Cardiomyopathy
Conditions: Heart Failure;   Myocardial Ischemia;   Angina Pectoris
Interventions: Drug: CK-1827452;   Drug: CK-1827452;   Drug: CK-1827452;   Drug: CK-1827452;   Drug: Placebo;   Drug: Placebo;   Drug: Placebo
5 Active, not recruiting ANDES-AGI-1067 as a Novel Antidiabetic Agent Evaluation Study
Condition: Diabetes
Interventions: Drug: Placebo;   Drug: AGI-1067;   Drug: AGI-1067
6 Recruiting LUME-Lung 1: BIBF 1120 Plus Docetaxel as Compared to Placebo Plus Docetaxel in 2nd Line Non-Small Cell Lung Cancer (NSCLC)
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: BIBF 1120;   Drug: placebo;   Drug: docetaxel
7 Recruiting Study of 400mcg Versus 800mcg Buccal Misoprostol Following Mifepristone 200mg for Abortion up to 63 Days Gestation
Condition: Induced Abortion
Interventions: Drug: Mifepristone, misoprostol;   Drug: mifepristone, misoprostol
8 Recruiting BRAVO Study: Laquinimod Double Blind Placebo Controlled Study in RRMS Patients With a Rater Blinded Reference Arm of Interferon β-1a (Avonex®)
Condition: Multiple Sclerosis
Interventions: Drug: laquinimod;   Drug: placebo;   Drug: Interferon β-1a (Avonex®)
9 Completed Phase 2 Dose-Ranging Study of SKY0402 for Prolonged Postoperative Analgesia in Subject Undergoing Hemorrhoidectomy
Condition: Postoperative Pain
Intervention: Drug: SKY0402
10 Active, not recruiting Comparative Study of Ceftaroline vs. Ceftriaxone in Adult Subjects With Community-Acquired Pneumonia
Condition: Bacterial Pneumonia
Interventions: Drug: ceftaroline;   Drug: ceftriaxone
11 Active, not recruiting Safety and Efficacy of Orally Administered Laquinimod for Treatment of Relapsing Remitting Multiple Sclerosis (RRMS)
Condition: Multiple Sclerosis
Interventions: Drug: Laquinimod;   Drug: Placebo
12 Recruiting A Study to Compare MPR With MP in Newly Diagnosed Multiple Myeloma Subjects 65 Years Old or Older
Condition: Newly Diagnosed Multiple Myeloma
Intervention: Drug: Lenalidomide
13 Recruiting A Phase I Study of AC220 in Patients With Relapsed/Refractory Acute Myeloid Leukemia Regardless of FLT3 Status
Conditions: Acute Myeloid Leukemia;   Leukemia;   Myelodysplastic Syndrome;   AML;   MDS
Intervention: Drug: AC220
14 Recruiting Study of LJP 394 in Lupus Patients With History of Renal Disease
Conditions: Lupus Erythematosus, Systemic;   Lupus Nephritis
Interventions: Drug: abetimus sodium (LJP 394) and/or placebo solution;   Drug: abetimus sodium (LJP 394);   Drug: Phosphate-buffered saline
15 Active, not recruiting A Phase III A Study to Assess the Safety of CDP870 for up to 30 Months Exposure
Condition: Crohn's Disease
Intervention: Biological: CDP870
16 Terminated Study of the Safety of VB6-845 in Patients With Advanced Solid Tumours of Epithelial Origin
Condition: Neoplasms, Glandular and Epithelial
Intervention: Drug: VB6-845
17 Recruiting A Study of CK-1827452 Infusion in Stable Heart Failure
Condition: Heart Failure
Interventions: Drug: CK-1827452;   Drug: CK-1827452;   Drug: CK-1827452;   Drug: CK-1827452;   Drug: CK-1827452;   Drug: CK-1827452;   Drug: CK-1827452;   Drug: CK-1827452;   Drug: Placebo;   Drug: Placebo;   Drug: CK-1827452;   Drug: Placebo
18 Active, not recruiting Pharmacokinetic Study of Tesmilifene (YMB1002) Plus Epirubicin and Cyclophosphamide in Metastatic Breast Cancer
Condition: Metastatic/Recurrent Breast Cancer
Intervention: Drug: Tesmilifene (YMB 1002)
19 Completed Study of Efficacy of Phenytoin in Therapy of Children With Bronchial Asthma
Condition: Bronchial Asthma
Intervention: Drug: Phenytoin
20 Recruiting VITATOPS: A Study of VITAmins TO Prevent Stroke
Conditions: Stroke;   Transient Ischemic Attack
Interventions: Drug: folic acid 2mg;   Drug: Vitamin B6 25mg;   Drug: Vitamin B12 500ug

Previous Page Studies Shown (1-20) Next (21-23)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services